Menu Close
The Conversation

Christina Polomoff

1

Article

0

Comments
Assistant Clinical Professor of Pharmacy Practice, University of Connecticut

I am a Population Health Clinical Pharmacist at Hartford HealthCare Integrated Care Partners where I manage the complex pharmacy care needs of high-risk patients, and implement population health management strategies that focus on medication-related performance metrics for the clinically integrated network.

I am also an Assistant Clinical Professor at the University of Connecticut School of Pharmacy where I serve as the faculty advisor for the Academy of Managed Care Pharmacy chapter, and as a core faculty member for the Leaders Track program. I co-chair the American Society of Consultant Pharmacists (ASCP) National Medication Safety During Transitions of Care Committee. I also serve on the Board of Directors for the ASCP Connecticut Chapter and the Connecticut Pharmacist Association, and hold an appointment on the State of Connecticut Department of Development Services Institutional Review Board.

I graduated from the University of Connecticut with a Doctor of Pharmacy and Business Minor. I completed a PGY1 residency at the VA Connecticut Healthcare System followed by a PGY2 ambulatory care residency at The Johns Hopkins Hospital. I hold dual board certifications in ambulatory care and geriatrics.

Experience

  • 2016–present
    Assistant Clinical Professor, University of Connecticut School of Pharmacy
  • 2016–present
    Population Health Clinical Pharmacist, Hartford HealthCare Integrated Care Partners

Education

  •  
    University of Connecticut School of Pharmacy, Credentials: PharmD, BCACP, BCGP. Title: Assistant Clinical Professor and Population Health Clinical Pharmacist

Publications

  • 2022
    Wagner J, Bermudez-Millan A, Berthold SM, Buckley T, Buxton OM, Feinn R, Kuoch T, Kong S, Lim M, Polomoff CM, Scully M. Risk factors for drug therapy problems among Cambodian Americans with complex needs: a cross-sectional, observational study, Health Psychology and Behavioral Medicine. 2022. 10:1, 145-159, DOI: 10.1080/21642850.2021.2021917,
  • 2022
    Polomoff CM, Dang DK, Chen JT. Adrenal Gland Disorders. In: Chisholm-Burns MA, Schwinghammer TL, Malone PM, Kolesar JM, Bookstaver P, Lee KC. eds. Pharmacotherapy Principles & Practice, 6e. McGraw Hill; 2022. ,
  • 2022
    Polomoff CM, Dang DK, Chen JT. Update to Acromegaly Management Guidelines. PPP Updates, 5 January 2022. McGraw Hill, 2022. Pharmacotherapy Principles & Practice. https://ppp.mhmedical.com/updatesContent.aspx?gbosid=578353&sectionid=262802435,
  • 2022
    Polomoff CM, Dang DK, Chen JT. Pituitary Gland Disorders. In: Chisholm-Burns MA, Schwinghammer TL, Malone PM, Kolesar JM, Bookstaver P, Lee KC. eds. Pharmacotherapy Principles & Practice, 6e. McGraw Hill; 2022.,
  • 2021
    Polomoff CM, Bermudez-Millan A, Buckley T, Buxton OM, Feinn R, Kong S, Kuoch T, Lim M, Scully M, Wagner J. Pharmacists and community health workers improve medication-related process outcomes among Cambodian Americans with depression and risk for diabetes. Journal of the American Pharmacists Association. In press. Published online Oct 2021. https://doi.org/10.1016/j.japh.2021.10.031,
  • 2020
    Gernant SA, Polomoff CM*, Marsh J, Martineau S, Hardie C, Jeffery SM. Pharmacists’ Experiences, Perceptions, and Knowledge of Direct-To-Consumer Prescription Coupons. J Manag Care Spec Pharm. 2020 Sep;26(9):1130-1137. ,
  • 2019
    Dang DK, Polomoff CM, Chen JT. Adrenal gland disorders. In: Chisholm MA, Schwinghammer TL, Wells BG, Kolesar JM, Malone PM, DiPiro JT, eds. Pharmacotherapy Principles and Practice, 5th ed. McGraw Hill, New York, 2019. p 703-718. ,
  • 2019
    Dang DK, Salvo MC, Polomoff CM. Chapter 9: Menstruation-Related Disorders. In: O'Connell M, Smith JA. eds. Women's Health Across the Lifespan, 2nd ed. McGraw-Hill, New York, 2019. ,

Grants and Contracts

  • 2021
    Medication Reconciliation and Polypharmacy Committee Best Possible Medication History User Interface Requirements Development
    Role:
    Site Principal Investigator
    Funding Source:
    State of Connecticut Office of Health Strategy
  • 2020
    Communicating Palliative Care Needs: creating enterprise-wide standard work to define, identify, and engage palliative care patients in advanced care planning, goal setting, and opportunities for deprescribing
    Role:
    Co-investigator
    Funding Source:
    Harvard Pilgrim Health Care
  • 2019
    Diabetes Risk Reduction through Eat, Walk, Sleep and Medication Therapy Management for Depressed Cambodians (DREAM) (Clinical Trials Identifier NCT02502929)
    Role:
    Co-investigator
    Funding Source:
    National Institutes of Health (NIH) / National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Professional Memberships

  • Academy of Managed Care Pharmacy (AMCP)
  • American Society of Consultant Pharmacists (ASCP)
  • American Pharmacists Association (APhA)
  • Connecticut Pharmacists Association (CPA)